Synthetic Biology for Enhanced Biosecurity:  New Genetic Circuits and Switches

As synthetic biology continues to evolve, the ability to control engineered organisms is more important now than ever. In this episode, B.Next's Dr. Kevin O'Connell is joined by Gabriel Lopez, the Co-founder and CEO of Synvivia, a company focused on building protein switches to control the behavior of genetically engineered organisms. Learn more about these protein switches, their commercial applications, how they can enhance biosecurity, and more. 

Learn more at synvivia.com